Literature DB >> 8593547

Medical complications of pregnancy in hereditary haemorrhagic telangiectasia.

C L Shovlin1, A R Winstock, A M Peters, J E Jackson, J M Hughes.   

Abstract

Hereditary haemorrhagic telangiectasia (HHT) displays significant variation in severity between affected individuals in the same family, ranging from relatively trivial epistaxis and telangiectasia to gastrointestinal, cerebral and pulmonary involvement. Evidence for successful therapy of HHT-related haemorrhage with oestrogens and progesterones, and recent case reports outlining pulmonary complications of pregnancy in HHT, prompted us to review the outcome of 161 pregnancies in 47 affected women. HHT-related maternal complications developed in eleven patients, ten in the subgroup of 23 pregnancies in which pulmonary arteriovenous malformations (PAVMs) were present at the outset, or documented in the two years following pregnancy. We present six cases of intrapulmonary shunt deterioration, two cases of fatal pulmonary haemorrhage and three cerebrovascular accidents related to pregnancy. A predisposition towards PAVMs in females was observed. Following the recent discovery of mutations in the endoglin gene in this disease, our data support a hypothesis of hormonal modification of the HHT phenotype. In addition, a significant excess of affected offspring are present in HHT families. We consider contributary aetiological factors, and discuss implications for patient management.

Entities:  

Mesh:

Year:  1995        PMID: 8593547

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  27 in total

Review 1.  Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms.

Authors:  C L Shovlin; M Letarte
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

Review 2.  Pulmonary arteriovenous malformations: a clinical review.

Authors:  M Iqbal; L J Rossoff; H N Steinberg; K A Marzouk; D N Siegel
Journal:  Postgrad Med J       Date:  2000-07       Impact factor: 2.401

Review 3.  Contemporary Management of Pulmonary Arteriovenous Malformations.

Authors:  Nicholas Rauh; John Gurley; Sibu Saha
Journal:  Int J Angiol       Date:  2017-09-18

4.  Potential role of modifier genes influencing transforming growth factor-beta1 levels in the development of vascular defects in endoglin heterozygous mice with hereditary hemorrhagic telangiectasia.

Authors:  A Bourdeau; M E Faughnan; M L McDonald; A D Paterson; I R Wanless; M Letarte
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

5.  A hereditary haemorrhagic telangiectasia family with pulmonary involvement is unlinked to the known HHT genes, endoglin and ALK-1.

Authors:  G M Wallace; C L Shovlin
Journal:  Thorax       Date:  2000-08       Impact factor: 9.139

6.  The value of screening for multiple arterio-venous malformations in hereditary hemorrhagic telangiectasia: a diagnostic study.

Authors:  Benedikt J Folz; Ana Cerra Wollstein; Heiko Alfke; Anja A Dünne; Burkard M Lippert; Konrad Görg; Hans-Joachim Wagner; Siegfried Bien; Jochen A Werner
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-12-17       Impact factor: 2.503

7.  Visceral manifestations in hereditary haemorrhagic telangiectasia type 2.

Authors:  S A Abdalla; U W Geisthoff; D Bonneau; H Plauchu; J McDonald; S Kennedy; M E Faughnan; M Letarte
Journal:  J Med Genet       Date:  2003-07       Impact factor: 6.318

8.  Mutant endoglin in hereditary hemorrhagic telangiectasia type 1 is transiently expressed intracellularly and is not a dominant negative.

Authors:  N Pece; S Vera; U Cymerman; R I White; J L Wrana; M Letarte
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

Review 9.  Novel biochemical pathways of endoglin in vascular cell physiology.

Authors:  Carmelo Bernabeu; Barbara A Conley; Calvin P H Vary
Journal:  J Cell Biochem       Date:  2007-12-15       Impact factor: 4.429

10.  Hereditary haemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations.

Authors:  J Berg; M Porteous; D Reinhardt; C Gallione; S Holloway; T Umasunthar; A Lux; W McKinnon; D Marchuk; A Guttmacher
Journal:  J Med Genet       Date:  2003-08       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.